Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Back
Association details:
Biomarker:
ABCG2 overexpression
Cancer:
Breast Cancer
Drug:
paclitaxel
(
Tubulin inhibitor
)
Direction:
Resistant
Evidence:
Evidence Level:
Resistant: D – Preclinical
Source:
Toxicol Appl Pharmacol
Title:
Characterization of acquired paclitaxel resistance of breast cancer cells and involvement of ABC transporters
Published date:
11/01/2016
Excerpt:
We found up-regulation of ABCG2/BCRP and ABCC4 proteins only in paclitaxel-resistant SK-BR-3 cells.
DOI:
10.1016/j.taap.2016.09.020
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.